Theradiag SA (ALTER) Dipped -0.88% on Jan 14

Shares of Theradiag SA (EPA:ALTER) last traded at 1.13, representing a move of -0.88%, or -0.01 per share, on volume of 27,762 shares. After opening the trading day at 1.17, shares of Theradiag SA traded in a close range. Theradiag SA currently has a total float of 8.56M shares and on average sees 14,789 shares exchange hands each day. The stock now has a 52-week low of 0.814 and high of 2.32.

Euronext Paris: Driving France’s Economic Prospects

France is one of Europe’s pride not just in the tourism front but most importantly, in the corporate world. One of the main reasons that Europe is immensely growing as an economy today is France. Its trading relations with Theradiag SA and other companies help both sides to grow further. The nation’s economic potentials cannot be undermined especially when they reflect in its own stable equity market.

Euronext Paris in History

Euronext Paris is part of a broader, pan-European stock exchange that stretches in five of the biggest European cities that include Paris, London, Lisbon, Brussels, and Amsterdam— the Euronext. It works with Theradiag SA as well. Some of the main Euronext indices include the AEX, AScX, CAC 40, Next 150, among others.

The Amsterdam Stock Exchange, the Brussels Stock Exchange, and the Paris Bourse had joined together on September 22, 2000, forming the first pan-European stock exchange. Two years later, the Bolsa de Valores de Lisboa e Porto (BVLP) had joined the Euronext. The foundation of a bigger, consolidated European stock exchange signifies the efforts of the European Union (EU) to maximize its resources and leverage better growth opportunities. Nearly two decades later and the Euronext continues to live up to its founding principle and mission— to drive the European economy towards meaningful success.

The CAC 40 is the free-float market capitalization-weighted index tracking the top 40 stocks on Euronext Paris. It represents a crucial aspect of the French economy as well as that of the European economy. Theradiag SA had to prove its reliability to appear at the market.

Prior to becoming a free-float market capitalization-weighted index on December 1, 2003, the CAC 40 had used to measure stocks based on overall market capitalization. Its name comes from an old automated trading system on the Euronext, CotationAssistéeenContinu.

The Index Steering Committee reviews the components of the CAC 40 every third Friday of March, June, September, and December. During these review dates, the Index Steering Committee limits the weights of each stock at 15%. The top 100 companies in terms of 12-month free-float market capitalization and share turnover are determined every quarter. From these 100 companies, the 40 most significant components are selected to make up the CAC 40.

Euronext Paris by the Numbers

As of the first quarter of 2014, the Euronext already had nearly €3 trillion of market capitalization with more than 1,000 companies.

The CAC 40 had reached an all-time high of nearly 7,000 on September 4, 2000, a few days before the establishment of the Euronext. Meanwhile, it had posted an all-time low of below 900 in January 1988.

The movement on Euronext Paris is in increments of 0.50. Stocks are weighted quarterly using a base value of 1,000, which was determined on December 31, 1987.

The margin requirement is usually 2% while the minimum trade size requirement is one index. As part of the EU, the main trading currency on Euronext Paris is euro.

Euronext Paris is one of the most influential stock exchanges not just in Europe but in the world as well. It boasts with stability and strong, long-term growth prospects. That being said, investing in Euronext Paris is a primary consideration among novice and experienced investors alike. Investors may be interested in Theradiag SA stocks.

More notable recent Theradiag SA (EPA:ALTER) news were published by: which released: “EPA to make it harder to tighten mercury rules in the future – The Washington Post” on December 28, 2018, also with their article: “Editorial: EPA tilts away from Americans – Newsday” published on January 03, 2019, published: “Stars Aligning for EPA Change in Calculating Air Rules Benefits – Bloomberg BNA” on August 31, 2018. More interesting news about Theradiag SA (EPA:ALTER) were released by: and their article: “Editorials DeWine’s road ahead – Toledo Blade” published on January 13, 2019 as well as‘s news article titled: “Would firing Scott Pruitt save the EPA? – The Washington Post” with publication date: May 22, 2018.

Theradiag SA engages in the development, industrialization, and marketing of diagnosis kits in France and internationally. The company has market cap of 9.67 million EUR. It offers auto-immunity products, such as FIDIS kits that allow detection of multiple analytes from the same sample in a single assay; immunofluorescence tests to screen and identify the auto-antibodies; ELISA tests for performing various tests simultaneously on the same plate; Chorus systems, a multi-parametric analyzer; and immunoblot tests, which allow simultaneous detection of antibodies. It currently has negative earnings. The firm also provides genetic tests comprising AmplideX products line for the diagnosis of the Fragile X syndrome and associated disorders; xTAG Gastrointestinal Pathogens Panel kits for identifying various gastrointestinal pathogens; xTAG Respiratory Viral Panel kits for identification of common respiratory viruses; and BCR/ABL1 Quant tests that are in vitro diagnostic products.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.